Given that Pin1 is downregulated and upregulated in AD and PD, respectively, precise modulations of Pin1 levels depending on the biological contexts might be one of the crucial factors to be considered in differential therapeutic strategies for treating AD and PD. This evidence concerns the gene PIN1 and Alzheimer disease.